Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19
ABSTRACT The outbreak of coronavirus disease 2019 (COVID-19), caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a threat to global health. The mortality rate of severely ill patients in the early stage is 32.5%. The exacerbation of the condition...
Guardado en:
Autores principales: | Yingjie Wu, Xiaoxing Huang, Jiaxing Sun, Tian Xie, Yufei Lei, Jamal Muhammad, Xinran Li, Xingruo Zeng, Fuling Zhou, Hong Qin, Liang Shao, Qiuping Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1d886a37d1ad4b3fba10cd297cf06889 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pentoxifylline as a Potential Adjuvant Therapy for COVID-19: Impeding the Burden of the Cytokine Storm
por: Wiktoria Feret, et al.
Publicado: (2021) -
La Saliva como Biomuestra para Diagnóstico de Infección por SARS-CoV-2: Una Revisión
por: Morales-Espinosa,Rolando
Publicado: (2020) -
Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19
por: Hayder M. Al-kuraishy, et al.
Publicado: (2021) -
Nature of the Interplay Between Periodontal Diseases and COVID-19
por: Wenji Cai, et al.
Publicado: (2021) -
Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications
por: Jamal Majidpoor, et al.
Publicado: (2022)